[1]
Marcin Schulz, Dawid Studziński and Anna Kołcz 2025. TIRZEPATIDE VERSUS SEMAGLUTIDE: A COMPREHENSIVE REVIEW OF COMPARATIVE EFFICACY, SAFETY, AND METABOLIC OUTCOMES IN TYPE 2 DIABETES AND OBESITY. International Journal of Innovative Technologies in Social Science. 5, 4(48) (Dec. 2025). DOI:https://doi.org/10.31435/ijitss.4(48).2025.4276.